References
- Albano C., Platteau P. and Devroey P. (2001) Gonadotropin-releasing hormone antagonist: how good is the new hope? Current Opinion in Obstetrics and Gynecology, 13, 257–262.
- Blithe D.L. (2001) Applications for GnRH antagonists. Trends in Endocrinology and Metabolism, 12, 238–240.
- Broekmans F.J., Hompes P.G., Heitbrink M.A., Netelenbos C.C., Roos J.C., Falke T.M. and Schoemaker J. (1996) Two-step gonadotropin-releasing hormone agonist treatment of uterine leiomyomas: standard-dose therapy followed by reduced-dose therapy. American Journal of Obstetrics and Gynecology, 175, 1208— 1216.
- Felberbaum R., Ludwig M. and Diedrich K. (2000) Clinical application of GnRH-antagonists. Molecular and Cellular Endocrinology, 166, 9 — 14.
- Friedman A.J., Daly M., Juneau-Norcross M. and Rein M.S. (1992) Predictors of uterine volume reduction in women with myomas treated with a gonadotropin-releasing hormone agonist. Fertility and Sterility, 58, 413–415.
- Huirne J.A. and Lambalk C.B. (2001) Gonadotropin-releasing- hormone-receptor antagonists. Lancet, 358, 1793–1803.
- Imai A. and Tayama T. (2000) GnRH receptor and apoptotic signaling. Vitamins and Hormones, 59, 1— 33.
- Klein N.A. and Soules M.R. (1998) Endocrine changes of the perimenopause. Clinical Obstetrics and Gynecology, 41, 912 — 920.
- Maheux R. and Lemay A. (1992) Treatment of peri-menopau-sal women: potential long-term therapy with a depot GnRH agonist combined with hormonal replacement therapy. British Journal of Obstetrics and Gynaecology, 99\(Suppl. 7), 13–17.
- Matta W.H., Shaw R. and Nye M. (1989) Long-term follow-up of patients with uterine fibroids after treatment with the LHRH agonist buserelin. British Journal of Obstetrics and Gynaecology, 96, 200–206.
- Muttukrishna S., Child T., Lockwood G., Groome N., Barlow D. and Ledger W. (2000) Serum concentrations of dimeric inhibins, activin A, gonadotrophins and ovarian steroids during the menstrual cycle in older women. Human Reproduction, 15, 549— 556.
- Palomba S., Affinito P., Tommaselli G. and Nappi C. (1998) A clinical trial of the effects of tibolone administered with gonadotropin-releasing hormone analogues for the treatment of uterine leiomata. Fertility and Sterility, 70, 111— 118.
- Shaw R.W. (1998) Gonadotrophin hormone-releasing hormone analogue treatment of fibroids. Baillieres Clinical Obstetrics and Gynaecology, 12, 245–268.